[go: up one dir, main page]

TW200800978A - Carbazole compound - Google Patents

Carbazole compound

Info

Publication number
TW200800978A
TW200800978A TW096108914A TW96108914A TW200800978A TW 200800978 A TW200800978 A TW 200800978A TW 096108914 A TW096108914 A TW 096108914A TW 96108914 A TW96108914 A TW 96108914A TW 200800978 A TW200800978 A TW 200800978A
Authority
TW
Taiwan
Prior art keywords
diseases
carbazole compound
salt
tract diseases
hydrogen atom
Prior art date
Application number
TW096108914A
Other languages
English (en)
Chinese (zh)
Inventor
Takeshi Kuroda
Takahito Yamauchi
Tomoichi Shinohara
Kunio Oshima
Chiharu Kitajima
Hitoshi Nagao
Hironobu Ishiyama
Kazuhide Ohta
Masaaki Takano
Takumi Sumida
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200800978A publication Critical patent/TW200800978A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW096108914A 2006-03-23 2007-03-15 Carbazole compound TW200800978A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006080451 2006-03-23

Publications (1)

Publication Number Publication Date
TW200800978A true TW200800978A (en) 2008-01-01

Family

ID=38171158

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096108914A TW200800978A (en) 2006-03-23 2007-03-15 Carbazole compound

Country Status (3)

Country Link
AR (1) AR059969A1 (fr)
TW (1) TW200800978A (fr)
WO (1) WO2007119600A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011150457A2 (fr) * 2010-06-01 2011-12-08 The University Of Queensland Inhibiteurs de la prostaglandine d2 synthase hématopoïétique
EP3321264A1 (fr) * 2016-11-14 2018-05-16 Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft Inhibiteurs sélectifs de voies d'ikk/nf-kb induites par un stress génotoxique
KR102643558B1 (ko) * 2017-06-05 2024-03-06 내셔널 유니버시티 오브 싱가포르 인간 트레포일 인자 3을 억제하는데 유용한 화합물
CN107698579B (zh) * 2017-11-23 2019-11-08 广东工业大学 一种咔唑衍生物、其制备方法及在抗肿瘤中的应用
WO2024079677A1 (fr) * 2022-10-15 2024-04-18 Pillai Universal Llc Nouvelle molécule thérapeutique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2381397A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
JP3812772B2 (ja) * 1997-10-03 2006-08-23 富士写真フイルム株式会社 熱現像感光材料
WO2003027081A2 (fr) * 2001-09-14 2003-04-03 Novo Nordisk A/S Nouveaux ligands pour les sites hisb10 zn2+ d'hexameres d'insuline en r
JP2003264010A (ja) * 2002-03-07 2003-09-19 Mitsubishi Paper Mills Ltd 光電変換素子
EP1997855A3 (fr) * 2002-07-29 2010-09-08 Mitsubishi Paper Mills Limited Colorant organique, matériel de transducteur photoélectrique, électrode à semi-conducteur, et dispositif de transduction photoélectrique
AU2003291972A1 (en) * 2002-12-20 2004-07-14 Novo Nordisk A/S Pharmaceutical compositions comprising insulin and legends of insulin hexamer
JP2008505866A (ja) * 2004-07-09 2008-02-28 ノボ ノルディスク アクティーゼルスカブ インスリンを含有する薬学的製剤

Also Published As

Publication number Publication date
WO2007119600A1 (fr) 2007-10-25
AR059969A1 (es) 2008-05-14
WO2007119600A9 (fr) 2008-05-02

Similar Documents

Publication Publication Date Title
TW200616961A (en) Carbostyril compound
MX2010002820A (es) Analogos de tiazolidindiona para tratamiento de hipertension.
WO2007095174A3 (fr) derives d'acides biliaires en tant que ligands de FXR pour la prevention ou le traitement de maladies ou d'etats induits par FXR
UA93872C2 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
WO2008019967A3 (fr) Dérivés phényliques, de la pyridine et de la quinoléine
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
MY149648A (en) Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
MX2010009752A (es) Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
IN2012DN00869A (fr)
WO2009025785A3 (fr) Ligands de récepteur cb2 pour le traitement de la douleur
TW200740760A (en) Malonamide derivatives
TW200612936A (en) Indole derivatives
MX2009012125A (es) Compuestos terapeuticos.
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
IL194057A0 (en) Pyrimidine, quinazoline, pteridine and triazine derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
TW200800978A (en) Carbazole compound
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
IL195747A0 (en) Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity
TW200626158A (en) Naphthaline derivatives
MX2009012518A (es) Derivados de piperidina 4,4-disubstituidos.
DE502005010342D1 (en) Substituierte cyclohexylessigsäure-derivate
MX2009013775A (es) Sustituto novedoso de piperidones sustituidas como inductor de hsp.